Semaglutide for Weight Loss in Non-Diabetics The FDA has approved semaglutide injections for chronic weight management in adults with obesity (a BMI of 30 or greater) or if youre merely overweight (a BMI of 27 or greater) and have at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol
doi:10.1172/JCI114666
If you drink, keep it minimal and avoid alcohol during the first few weeks of each dose increase
This delayed gastric emptying creates a sensation of fullness and reduces hungerbut it also triggers nausea in some patients
Key Benefits: Clinically proven results with consistent use Non-surgical and minimally invasive Reduces cravings and emotional eating Improves metabolic health Supports long-term weight maintenance Many patients report not only losing weight but also gaining confidence, energy, and better overall well-being
That said, some providers do recommend stepping down the dose gradually rather than stopping all at once, and there are practical reasons for this approach